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Materials and methods: The effect on MPO activity was
assessed after oral administration of the microparticulate L.
casei formulation (once daily during 21 days; probiotic viability
8,7 log10cfu/g) to Wistar rats in which inflammation was induced
by intrarectal administration of TNBS (10 mg in 0.25 ml 50%
ethanol). For comparison, a group of Wistar rats received the
same amount of non-encapsulated L.casei (8,7 log10cfu/g). At
the same time, a negative and a positive (TNBS) control group
were also tested. The MPO activity was measured as described
by Peran et al., 2007 [4]..
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Introduction: The hypothesis that the intestinal bacterial flora contributes to the pathogenesis of inflammatory bowel disease (IBD) has
been supported by experimental and clinical evidence [1]. The dysbiosis present in this condition is related to dysregulation of mucosal
immune response. One of the indicators of leukocyte infiltration at the sites of inflammation is the activity of myeloperoxidase (MPO) [2].
Numerous studies have been conducted in order to examine the effects of probiotic intake in IBD. However, during ingestion of
probiotics, the harsh conditions which are present in the gastrointestinal (GI) tract often impair the delivery of viable microorganisms in
the lower intestine. For this reason, probiotic (Lactobacillus casei 01) was incorporated in Ca-alginate-microparticles coated with whey
protein [3] and the effects of the formulation were examined in rat model of TNBS (trinitrobenzene sulfonic acid) - derived colitis.
The objective of this work was to examine the lower intestine MPO activity after induction of TNBS colitis in rats, and to compare the
effects of ingestion of microparticulate probiotic formulation vs non-encapsulated probiotic.
CONCLUSION
Although the antioxidative influence of probiotics to cells is still
to be explored, the role of probiotic molecules to reactive
oxygen species is rather unraveled. Having the survival of
probiotics a major issue to address, our results showed that
encapsulation might be a strategy that leads to better outcome
of probiotic action, since we observed lowered MPO activity in
our encapusulated probiotic formulation in this model of colitis in
rats. As other object of further research, other indicators of gut
wall immune response should be examined in order to confirm
and support the current finding that microencapsulated probiotic
confer better effects than non-encapsulated one.
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Fig. 1: Groups of treated Wistar rats that were examined for MPO activity.
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Results and discussion: The obtained values of MPO
confirmed the presence of inflammation in TNBS rat model of
colitis, with the highest activity noted in the positive (TNBS)
control group as was initially expected, due to the known effect
of this hapten-induced inflammation. The activity of MPO was
found to be lower in the group of rats that were administered a
microparticulate probiotic formulation, in comparison to the
group that was administered non-encapsulated probiotic.
These results suggest that encapsulation of L. casei efficiently
protects the probiotic during the GI transit, therefore resulting
in better colonization of the lower intestine, which
subsequently results in lower MPO activity.
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Fig. 2: Levels of MPO (U/g tissue) in the examined groups of rats.
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